By apyxmedical In 2018 Shareholder News, J-PlasmaPosted December 21, 2018BOVIE MEDICAL CORPORATION FILES 510(K) SUBMISSION WITH THE FDA FOR A NEW INDICATION TO MARKET AND SELL J-PLASMA/RENUVION FOR USE IN DERMAL RESURFACING PROCEDURES READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted December 17, 2018BOVIE MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF TARA H. SEMB AS CHIEF FINANCIAL OFFICER READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted December 12, 2018BOVIE MEDICAL CORPORATION ANNOUNCES CORPORATE NAME CHANGE TO APYX MEDICAL CORPORATION AND PLANS TO TRANSITION COMMON STOCK LISTING TO NASDAQ GLOBAL SELECT MARKET READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted November 19, 2018BOVIE MEDICAL CORPORATION TO PARTICIPATE IN THE PIPER JAFFRAY 30TH ANNUAL HEALTHCARE CONFERENCE READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted November 13, 2018BOVIE MEDICAL CORPORATION ANNOUNCES FUTURE RETIREMENT OF JAY D. EWERS, CHIEF FINANCIAL OFFICER, TREASURER AND SECRETARY READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted November 1, 2018BOVIE MEDICAL CORPORATION REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2018 OUTLOOK READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted October 31, 2018BOVIE MEDICAL CORPORATION TO PARTICIPATE IN THE 9TH ANNUAL CRAIG-HALLUM ALPHA SELECT CONFERENCE READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted October 22, 2018BOVIE MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF LAURA IVERSEN AS DIRECTOR OF GLOBAL OPERATIONS FOR ADVANCED ENERGY READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted October 3, 2018BOVIE MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2018 FINANCIAL RESULTS ON NOVEMBER 1, 2018 READ MORE
By apyxmedical In 2018 Shareholder News, J-PlasmaPosted September 11, 2018BOVIE MEDICAL CORPORATION TO PRESENT AT THE SIDOTI & COMPANY FALL 2018 INVESTOR CONFERENCE READ MORE